Clinical Trial Update: A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism [Phase 2]

View source ↗

Summary

Phase 2 trial of donepezil for sleep enhancement and behavioral change in children with autism was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Autism Spectrum Disorders | Phase 2 | Status: TERMINATED | Results posted: 2017-09-25